Can Whole-body Low-dose Multidetector CT Exclude the Presence of Myeloma Bone Disease in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)?

Academic Radiology

Volumn 19, Issue 1, 2012, Pages 89-94

  Spira, Daniel ^a   Weisel, Katja ^a   Brodoefel, Harald ^b   Schulze, Maximilian ^a   Kaufmann, Sascha ^a   Horger, Marius ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

MGUS; Monoclonal gammopathy of undetermined significance; WBLD CT; Whole body low dose multidetector CT

Indexed keywords

ANTIDEPRESSANT AGENT; M PROTEIN;

ADULT; AGED; ANEMIA; ARTICLE; BONE DISEASE; BONE MARROW; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHY SCANNER; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIPLE MYELOMA; OSTEOLYSIS; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; WHOLE BODY CT;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MIDDLE AGED; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MULTIPLE MYELOMA; RADIATION DOSAGE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 82955177115     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2011.09.016     Document Type: Article

References (25)

1. Kyle R.A., Therneau T.M., Rajkumar S.V., et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006, 354:1362-1369.
2. Kyle R.A., Rajkumar S.V. Monoclonal gammopathy of undetermined significance. Br J Haematol 2006, 134:573-589.
3. Kyle R.A., Therneau T.M., Rajkumar S.V., et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002, 346:564-569.
4. Landgren O., Kyle R.A., Pfeiffer R.M., et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009, 113:5412-5417.
5. Durie B.G., Salmon S.E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975, 36:842-854.
6. Horger M., Claussen C.D., Bross-Bach U., et al. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography. Eur J Radiol 2005, 54:289-297.
7. Mahnken A.H., Wildberger J.E., Gehbauer G., et al. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. AJR Am J Roentgenol 2002, 178:1429-1436.
8. Fechtner K., Hillengass J., Delorme S., et al. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems. Radiology 2010, 257:195-204.
9. Horger M., Pereira P., Claussen C.D., et al. Hyperattenuating bone marrow abnormalities in myeloma patients using whole-body non-enhanced low-dose MDCT: correlation with haematological parameters. Br J Radiol 2008, 81:386-396.
10. Vande Berg B.C., Michaux L., Lecouvet F.E., et al. Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome. Radiology 1997, 202:247-251.
11. Bäuerle T., Hillengass J., Fechtner K., et al. Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging. Radiology 2009, 252:477-485.
12. Durie B.G., Kyle R.A., Belch A., et al. Scientific Advisors of the International Myeloma Foundation. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J 2003, 4:379-398.
13. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003, 121:749-757. International Myeloma Working Group.
14. Cosentini T., Le Donne R., Mancini D., et al. Magnetic resonance imaging evaluation of bone marrow changes in obstructive sleep apnoea syndrome in adults. Radiol Med 2006, 111:572-584.
15. Poulton T.B., Murphy W.D., Duerk J.L., et al. Bone marrow reconversion in adults who are smokers: MR imaging findings. AJR Am J Roentgenol 1993, 161:1217-1221.
16. Kyle R.A., Durie B.G., Rajkumar S.V., et al. International Myeloma Working Group. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 2010, 24:1121-1127.
17. Landgren O. Monoclonal gammopathy of undetermined significance and smoldering myeloma: new insights into pathophysiology and epidemiology. Hematol Am Soc Hematol Educ Program 2010, 2010:295-302.
18. Bladé J. Clinical practice. Monoclonal gammopathy of undetermined significance. N Engl J Med 2006, 355:2765-2770.
19. Bladé J., Rosiñol L., Cibeira M.T., et al. Pathogenesis and progression of monoclonal gammopathy of undetermined significance. Leukemia 2008, 22:1651-1657.
20. Pepe J., Petrucci M.T., Nofroni I., et al. Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. Br J Haematol 2006, 134:485-490.
21. Kristinsson S.Y., Pfeiffer R.M., Björkholm M., et al. Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood 2010, 115:4991-4998.
22. Lecouvet F.E., Vande Berg B.C., Michaux L., et al. Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology 1998, 209:653-660.
23. Sager S., Ergül N., Ciftci H., et al. The value of FDG PET/CT in the initial staging and bone marrow involvement of patients with multiple myeloma. Skeletal Radiol 2011, [Epub ahead of print].
24. Horger M., Kanz L., Denecke B., et al. The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma. Cancer 2007, 109:1617-1626.
25. Huang B., Li J., Law M.W., et al. Radiation dose and cancer risk in retrospectively and prospectively ECG-gated coronary angiography using 64-slice multidetector CT. Br J Radiol 2010, 83:152-158.